Lohmann, Lisa 1992-
VIAF ID: 9004159109715206900005 (Personal)
Permalink: http://viaf.org/viaf/9004159109715206900005
Preferred Forms
-
100 1 _
‡a
Lohmann, Lisa
‡d
1992-
4xx's: Alternate Name Forms (1)
5xx's: Related Names (1)
Works
| Title | Sources |
|---|---|
| Immune cell profiling during switching from natalizumab to fingolimod reveals differential effects on systemic immune-regulatory networks and on trafficking of Non-T cell populations into the Cerebrospinal Fluid - results from the ToFingo successor study |
|
| Impact of disease-modifying therapies on humoral and cellular immune-responses following SARS-CoV-2 vaccination in MS patients |
|
| Severe disease exacerbation after mRNA COVID-19 vaccination unmasks suspected multiple sclerosis as neuromyelitis optica spectrum disorder: a case report |
|
| Status of clinical research in neurology in Germany - a national survey |
|
